Consensus Revelation Biosciences, Inc.

Equities

Market Closed - Nasdaq Other stock markets 04:30:00 2024-05-10 pm EDT			5-day change	1st Jan Change
2.06 ^USD	-6.36%		-13.08%	-86.29%

Mar. 22	Revelation Biosciences, Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023	CI
Mar. 22	Revelation Biosciences, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	CI

190661b8e4.afKO2RgXmvGIda8AsTQlZlQ251A-8WhsjIDoqRP1d4U.JaHmrypN75ulA-Vj3EATFT10vhtShCIvwue4nlChHrA_tr-PVHLAx-oyzA~e0b34add31ee6ad97d8a19c21a294662

Exchange-Traded Funds Higher, Equity Futures Mixed Pre-Bell Thursday on Unchanged Fed Rate, Upcoming Earnings	Feb. 01	MT
Roth MKM Adjusts Price Target on Revelation Biosciences to $15 From $5, Maintains Buy Rating	23-02-14	MT
Wall Street Set for Gains, Rate Decision Eyed	22-07-25	MT

Sell

Buy

Mean consensus

OUTPERFORM

Number of Analysts

Last Close Price

2.06 USD

Average target price

32.12 USD

Spread / Average Target

+1,459.47%

High Price Target

39.25 USD

Spread / Highest target

+1,805.34%

Low Price Target

25 USD

Spread / Lowest Target

+1,113.59%

Roth MKM